Relevance of Phytochemical Taste for Anti-Cancer Activity: A Statistical Inquiry.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
12 Nov 2023
Historique:
received: 23 09 2023
revised: 06 11 2023
accepted: 10 11 2023
medline: 27 11 2023
pubmed: 25 11 2023
entrez: 25 11 2023
Statut: epublish

Résumé

Targeting inflammation and the pathways linking inflammation with cancer is an innovative therapeutic strategy. Tastants are potential candidates for this approach, since taste receptors display various biological functions, including anti-inflammatory activity (AIA). The present study aims to explore the power different tastes have to predict a phytochemical's anti-cancer properties. It also investigates whether anti-inflammatory phytocompounds also have anti-cancer effects, and whether there are tastes that can better predict a phytochemical's bivalent biological activity. Data from the PlantMolecularTasteDB, containing a total of 1527 phytochemicals, were used. Out of these, only 624 phytocompounds met the inclusion criterion of having 40 hits in a PubMed search, using the name of the phytochemical as the keyword. Among them, 461 phytochemicals were found to possess anti-cancer activity (ACA). The AIA and ACA of phytochemicals were strongly correlated, irrespective of taste/orosensation or chemical class. Bitter taste was positively correlated with ACA, while sweet taste was negatively correlated. Among chemical classes, only flavonoids (which are most frequently bitter) had a positive association with both AIA and ACA, a finding confirming that taste has predictive primacy over chemical class. Therefore, bitter taste receptor agonists and sweet taste receptor antagonists may have a beneficial effect in slowing down the progression of inflammation to cancer.

Identifiants

pubmed: 38003415
pii: ijms242216227
doi: 10.3390/ijms242216227
pmc: PMC10671173
pii:
doi:

Substances chimiques

Anti-Inflammatory Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Nutrients. 2017 Jun 24;9(7):
pubmed: 28672790
Nutrients. 2021 Feb 04;13(2):
pubmed: 33557387
Eur J Cancer Prev. 2022 Jan 1;31(1):35-43
pubmed: 33470689
J Cancer Prev. 2021 Dec 30;26(4):224-236
pubmed: 35047448
Nature. 2018 Aug;560(7719):499-503
pubmed: 30051890
Handb Exp Pharmacol. 2014;223:827-71
pubmed: 24961971
Genes Nutr. 2011 May;6(2):109-15
pubmed: 21484164
Am J Med. 1998 May;104(5):413-21
pubmed: 9626023
J Gen Physiol. 2017 Feb;149(2):181-197
pubmed: 28053191
Cancer Cell Int. 2021 Nov 25;21(1):622
pubmed: 34823532
Eur J Pharmacol. 2021 Nov 5;910:174480
pubmed: 34496302
Semin Cancer Biol. 2012 Feb;22(1):33-40
pubmed: 22210179
Cancer Prev Res (Phila). 2016 Aug;9(8):683-91
pubmed: 27267893
J Natl Cancer Inst. 2019 Feb 1;111(2):137-145
pubmed: 29860330
J Ethnopharmacol. 2015 Nov 4;174:464-73
pubmed: 26320686
Planta Med. 2022 Oct;88(13):1123-1131
pubmed: 34763354
Mol Cell Biochem. 2017 Feb;426(1-2):137-147
pubmed: 28012014
J Agric Food Chem. 2021 Nov 17;69(45):13339-13349
pubmed: 33461297
J Ethnopharmacol. 2018 Jun 28;220:129-146
pubmed: 29604378
Nutrients. 2019 Oct 05;11(10):
pubmed: 31590362
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Int J Mol Sci. 2023 May 11;24(10):
pubmed: 37239974
Open Biol. 2022 Sep;12(9):220124
pubmed: 36099932
Cancer Immunol Res. 2014 Sep;2(9):823-30
pubmed: 25187272
Oncol Lett. 2015 Mar;9(3):1015-1026
pubmed: 25663851
Front Physiol. 2019 Oct 02;10:1267
pubmed: 31632299
Adv Urol. 2012;2012:181987
pubmed: 22778725
Evid Based Complement Alternat Med. 2022 Nov 23;2022:5227335
pubmed: 36467557
Nutrients. 2023 May 31;15(11):
pubmed: 37299548
PLoS Med. 2022 Mar 24;19(3):e1003950
pubmed: 35324894
Sci Rep. 2017 Apr 11;7:46166
pubmed: 28397820
Int J Mol Sci. 2019 Mar 20;20(6):
pubmed: 30897734
J Clin Invest. 2014 Mar;124(3):1393-405
pubmed: 24531552
Sci Rep. 2017 Sep 21;7(1):12074
pubmed: 28935887
Planta Med. 2010 Aug;76(11):1103-17
pubmed: 20432202
J Clin Med. 2020 Nov 18;9(11):
pubmed: 33217986
Curr Opin Clin Nutr Metab Care. 2014 Jul;17(4):379-85
pubmed: 24763065
PLoS One. 2017 May 3;12(5):e0176851
pubmed: 28467517
Int J Mol Sci. 2023 Feb 13;24(4):
pubmed: 36835162
Curr Pharm Biotechnol. 2014;15(10):951-61
pubmed: 25248559
J Natl Cancer Inst. 2023 May 8;115(5):570-577
pubmed: 36744914
Clin Lung Cancer. 2023 May;24(3):287-294
pubmed: 36804711
World J Otorhinolaryngol Head Neck Surg. 2018 Aug 24;4(3):200-208
pubmed: 30506052
Int J Food Sci Nutr. 2010 May;61(3):324-36
pubmed: 20402549
Br J Cancer. 2003 Nov 17;89(10):1876-84
pubmed: 14612896
Curr Cancer Drug Targets. 2013 Jun;13(5):542-57
pubmed: 23597198
Pol J Food Nutr Sci. 2019;69(3):219-233
pubmed: 31938015
Wiley Interdiscip Rev Syst Biol Med. 2017 Mar;9(2):
pubmed: 27943646
Mol Carcinog. 2020 Mar;59(3):265-280
pubmed: 31867776
FEBS J. 2021 Apr;288(8):2660-2672
pubmed: 33590961
Int J Cancer. 2021 Apr 5;:
pubmed: 33818764
J Cancer. 2017 Oct 17;8(18):3707-3717
pubmed: 29151958
Nat Rev Cancer. 2016 Mar;16(3):173-86
pubmed: 26868177
Front Oncol. 2020 Jul 24;10:1225
pubmed: 32793492
Biochem Biophys Res Commun. 2014 Apr 4;446(2):499-503
pubmed: 24613843
Ir J Med Sci. 2017 Feb;186(1):57-62
pubmed: 27156054
Sci Rep. 2022 May 27;12(1):8937
pubmed: 35624283
Front Immunol. 2020 Mar 10;11:324
pubmed: 32210957
BMC Cancer. 2005 Dec 12;5:159
pubmed: 16343343
Cell Mol Life Sci. 2020 Feb;77(3):531-542
pubmed: 31236627
Front Oncol. 2021 Jul 08;11:703558
pubmed: 34307172
Evid Based Complement Alternat Med. 2017;2017:5435831
pubmed: 28642799
Life Sci. 2023 Feb 15;315:121363
pubmed: 36610638
Cancer Prev Res (Phila). 2021 Aug;14(8):795-802
pubmed: 34244153
Mol Oncol. 2022 Apr;16(7):1474-1492
pubmed: 34717036
Int J Mol Sci. 2020 Apr 09;21(7):
pubmed: 32283655
Annu Rev Pathol. 2016 May 23;11:421-49
pubmed: 27193454
Front Immunol. 2021 Dec 15;12:726546
pubmed: 34975834
Ann Transl Med. 2020 Mar;8(6):385
pubmed: 32355829
Front Pharmacol. 2022 Jan 12;12:751712
pubmed: 35095484
Food Funct. 2014 Dec;5(12):3040-54
pubmed: 25286017
Mol Cell Biochem. 2020 Feb;465(1-2):199-214
pubmed: 31894529
Cancer Res. 1988 Jun 1;48(11):3140-7
pubmed: 3130187
Exp Hematol. 2006 Apr;34(4):399-406
pubmed: 16569586
Plants (Basel). 2022 Nov 06;11(21):
pubmed: 36365444
Int J Cancer. 2007 Feb 15;120(4):859-67
pubmed: 17131317
Br J Haematol. 2013 Mar;160(5):714-7
pubmed: 23205612
Chem Senses. 2020 Nov 7;45(8):667-673
pubmed: 32832995
Br J Cancer. 1995 Dec;72(6):1412-9
pubmed: 8519653
Front Immunol. 2021 Apr 15;12:664371
pubmed: 33936102
Mol Cell Biochem. 2019 Apr;454(1-2):203-214
pubmed: 30350307
Biomed Res Int. 2017;2017:4734127
pubmed: 29119107
Cancers (Basel). 2021 Nov 23;13(23):
pubmed: 34885005
Cancer Cell Int. 2019 Jul 15;19:180
pubmed: 31341423
J Lab Clin Med. 1993 Nov;122(5):518-23
pubmed: 8228569
Cancer Chemother Pharmacol. 2018 Oct;82(4):695-706
pubmed: 30074076
Curr Med Chem. 2013;20(10):1323-31
pubmed: 23298135
Front Nutr. 2019 Nov 15;6:174
pubmed: 31803750
BMC Cancer. 2023 Apr 17;23(1):354
pubmed: 37069504
Curr Opin Endocrinol Diabetes Obes. 2020 Apr;27(2):110-114
pubmed: 32073429
Nat Rev Cancer. 2013 Nov;13(11):759-71
pubmed: 24154716
Cancers (Basel). 2023 Jan 12;15(2):
pubmed: 36672434
Front Biosci (Landmark Ed). 2018 Jun 1;23(12):2255-2266
pubmed: 29772560
Nat Rev Immunol. 2018 May;18(5):309-324
pubmed: 29379212
J Cell Physiol. 2019 May;234(5):5683-5699
pubmed: 30341914
Trends Mol Med. 2010 May;16(5):230-7
pubmed: 20434954
Immunol Rev. 2012 Mar;246(1):379-400
pubmed: 22435567
Immunity. 2019 Jul 16;51(1):27-41
pubmed: 31315034
Front Oncol. 2022 Apr 22;12:854946
pubmed: 35530357
Front Oncol. 2023 Jan 27;13:1099811
pubmed: 36776289
Pharmaceuticals (Basel). 2023 Mar 03;16(3):
pubmed: 36986488
JAMA Netw Open. 2019 Jun 5;2(6):e195718
pubmed: 31199446
Front Nutr. 2022 Apr 04;9:881177
pubmed: 35445064
Naunyn Schmiedebergs Arch Pharmacol. 2011 Sep;384(3):221-30
pubmed: 21800094
Physiol Behav. 2011 Nov 30;105(1):4-13
pubmed: 21324331
Front Pharmacol. 2020 May 29;11:819
pubmed: 32547404
Nutrients. 2019 May 24;11(5):
pubmed: 31137645
Onco Targets Ther. 2018 Apr 11;11:2063-2073
pubmed: 29695914
Cancer Metastasis Rev. 2011 Dec;30(3-4):449-63
pubmed: 22002714
Toxicol Appl Pharmacol. 2022 Nov 15;455:116265
pubmed: 36208701
Phytochemistry. 2015 May;113:24-32
pubmed: 25556315
Am J Med. 1999 May 31;106(5B):37S-42S
pubmed: 10390126
J Immunother Cancer. 2020 Jun;8(1):
pubmed: 32554609
J Ethnopharmacol. 2015 Dec 24;176:365-74
pubmed: 26593213
Cancer Discov. 2022 Jan;12(1):31-46
pubmed: 35022204
World J Gastroenterol. 2016 May 28;22(20):4794-801
pubmed: 27239106
Compr Physiol. 2021 Sep 23;11(4):2489-2523
pubmed: 34558667
Neurosci Lett. 2019 May 1;700:56-63
pubmed: 29679682
J Biol Chem. 2016 Mar 4;291(10):5068-79
pubmed: 26792858
Precis Cancer Med. 2021 Sep;4:
pubmed: 35098108
Cancer Discov. 2022 Jan;12(1):90-107
pubmed: 34789537
Int Immunopharmacol. 2012 Jul;13(3):271-9
pubmed: 22564506
Nat Rev Clin Oncol. 2015 Oct;12(10):584-96
pubmed: 26122183
Cell Mol Life Sci. 2008 Oct;65(19):2979-99
pubmed: 18516495
Cell Mol Life Sci. 2015 Jan;72(2):217-36
pubmed: 25323130
Lancet. 2020 Jun 13;395(10240):1855-1863
pubmed: 32534647
Prostate. 2019 May;79(6):614-621
pubmed: 30671976
Arch Intern Med. 2011 Sep 12;171(16):1487-93
pubmed: 21911634
Lancet. 2017 Oct 21;390(10105):1833-1842
pubmed: 28855077
J Agric Food Chem. 2023 May 10;71(18):6789-6802
pubmed: 37102791
Commun Biol. 2023 Jun 7;6(1):612
pubmed: 37286811
Biochim Biophys Acta. 2014 Dec;1846(2):405-24
pubmed: 25152445
Phytother Res. 2022 Apr;36(4):1797-1806
pubmed: 35178811
Food Chem (Oxf). 2022 Feb 21;4:100090
pubmed: 35415670
BMC Cancer. 2018 Mar 13;18(1):288
pubmed: 29534696

Auteurs

Teodora-Cristiana Grădinaru (TC)

Department of Functional Sciences I/Biochemistry, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Marilena Gilca (M)

Department of Functional Sciences I/Biochemistry, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Adelina Vlad (A)

Department of Functional Sciences I/Physiology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Dorin Dragoș (D)

Department of Medical Semiology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
1st Internal Medicine Clinic, University Emergency Hospital Bucharest, Carol Davila University of Medicine and Pharmacy, 050098 Bucharest, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH